Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
about
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptideMas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalizationComparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wallKeratinocyte production of cathelicidin provides direct activity against bacterial skin pathogensPeptidoglycan recognition protein 2 (N-acetylmuramoyl-L-Ala amidase) is induced in keratinocytes by bacteria through the p38 kinase pathway.The skin microbiomeAllergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent mannerCAMP: a useful resource for research on antimicrobial peptidesThe vitamin D-antimicrobial peptide pathway and its role in protection against infectionAntimicrobial peptides and the skin immune defense systemThe role of microorganisms in atopic dermatitisMolecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic DermatitisSézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and TargetsThe role of antimicrobial peptides in chronic inflammatory skin diseasesAdvances in understanding and managing atopic dermatitisThe Innate Immune System in Acute and Chronic WoundsInhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced InflammationCathelicidin impact on inflammatory cells"TRP inflammation" relationship in cardiovascular systemRegulation of T Cell Immunity in Atopic Dermatitis by Microbes: The Yin and Yang of Cutaneous InflammationRegulation of Dendritic Cell Function in InflammationThe skin microbiome: a focus on pathogens and their association with skin diseaseSTAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertaintiesDeciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesHyper-IgE syndrome updateCholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and diseaseNew era of biologic therapeutics in atopic dermatitisSystemic therapy for atopic dermatitisAntiviral potential of cathelicidinsThe new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasisEpidermal permeability barrier defects and barrier repair therapy in atopic dermatitisStructural and Functional Analysis of the Pro-Domain of Human Cathelicidin, LL-37Host-pathogen interactions between the skin and Staphylococcus aureus.High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.The Pathogenetic Effect of Natural and Bacterial Toxins on Atopic DermatitisCancers Related to Immunodeficiencies: Update and PerspectivesNovel insights into the role of immune cells in skin and inducible skin-associated lymphoid tissue (iSALT)Interactions between host factors and the skin microbiomeAntimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsMast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis
P2860
Q21090025-59A50055-D310-4B35-9055-249963271934Q24296488-BA93A075-C17A-492F-AFC1-38EFDC98F348Q24300909-6D480E75-B159-42CF-8FFD-D3C93FCF8032Q24336171-E3DCAB0A-223F-4A87-B825-B5B29B22B312Q24536081-634A8A82-1891-4826-A44F-23F1F0FB4E31Q24634180-28D5083B-E762-40FD-AD15-D651750B2D36Q24634886-ED97D7F5-E358-4495-B1F7-39E76259BF25Q24644249-9EF7D6C2-9A95-4C1B-BEDD-348DF384AB85Q24647840-9EAED10C-F410-4A18-B783-FDB8C856030BQ24654981-57454049-5F1E-4C8F-9861-FA1EB980E02BQ24683941-3A4B4ACC-076B-4718-B92B-D64DDB943212Q26739986-C550D42E-504F-4F7C-A9AF-5D3BEFCBD045Q26746551-471835E9-85D6-4884-A6E6-9CCAB74AA9EFQ26764915-46FA9D34-1CB9-429B-ADC3-9E384182158AQ26766224-BC00547C-566F-4C8A-BAEE-C9E315E8FC4CQ26767062-4FA07EA8-EE71-4C73-AF8C-A7600E0D9AD0Q26776409-9161947B-DD72-4ECA-AF16-EFCCF7BB6930Q26777983-8260FF9D-646E-41B8-A9DA-CA6856609544Q26781720-81709CC0-747E-4AB4-A18E-BAD7F1B8AA79Q26798464-9DBBB295-1963-4EE4-BE83-F09B5E30A88CQ26800988-F94B43E2-2D35-4EBD-9E68-E1E550F4ABBBQ26827991-0086AD62-4305-4DA5-B399-1E9D3CDB596AQ26829298-9633D98B-8F87-4611-866F-BC670E849165Q26852335-E6320D6E-A2B6-4D5F-856B-E75E07AF780BQ26994673-5B0E3D6A-4865-42B7-87AA-02B4F65736B8Q26998399-95BD0881-736E-48A1-AAC0-3034D5636E04Q27001941-0A04258E-87DB-4E3B-B8F2-D3DA961D12E0Q27005835-54722E35-F108-42A8-A4BB-BD989F16C5F2Q27006576-D5F3373E-889C-44A9-B6AE-4C553D723788Q27007680-A7622A33-F1A7-4C9C-8DB4-A8F2C3D2EE8DQ27024192-86827B7E-1E81-49E8-8172-435C41964B2BQ27676356-0BA21405-E51E-4BCC-A1E7-5CE05EF8D53DQ27692552-73881EEF-C1F2-4E5C-A607-5DCC6C13ABD7Q27692605-678193AB-FF05-4267-B872-F9DE20043FB8Q28068840-7ABD0B6B-CFB4-4655-89F2-0770DF6FC0E7Q28074182-E0D4EC23-C8DE-4624-A422-8F7841C13D4EQ28081241-FCF88FCB-8DB4-4C87-B87E-C266C8D7C07AQ28082916-99740A0B-26A0-4651-9A28-24FE77A20213Q28087327-623E2EC1-022E-41B7-9C4B-787E8AEB5234Q28238414-6CED25C1-68C3-49DD-A928-6F55C1A377FB
P2860
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
@en
type
label
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
@en
prefLabel
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
@en
P2093
P356
P1476
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
@en
P2093
Corinne Brandt
Donald Y M Leung
Ian Strickland
Mark Boguniewicz
Peck Y Ong
Richard L Gallo
Takaaki Ohtake
P304
P356
10.1056/NEJMOA021481
P407
P50
P577
2002-10-01T00:00:00Z